Medicare Enrolled
Dr. Emily Guhl, MD
Cardiovascular Disease · Leetsdale, PA
Practice pattern: Cardiac Imaging
— Practice with significant diagnostic imaging and stress testing
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Guhl from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Guhl?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Guhl
Dr. Emily Guhl is a cardiovascular disease specialist in Leetsdale, PA, with 12 years of NPI registration. Based on federal Medicare data, Dr. Guhl performed 2,002 Medicare services across 1,696 unique beneficiaries.
Between the years covered by Open Payments, Dr. Guhl received a total of $4,768 from 26 pharmaceutical and/or device companies across 151 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Guhl is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 12 years in practice
▲ Top 41% volume in PA
$4,768 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,002
Medicare services
Top 41% in PA for cardiovascular disease
1,696
Unique beneficiaries
$48
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~167 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
805 | $6 | $51 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
261 | $83 | $199 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
222 | $134 | $873 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
104 | $38 | $125 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
70 | $60 | $123 |
| Perflutren lipid microspheres injection Injection of perflutren lipid microspheres, measured per milliliter. |
48 | $36 | $234 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
42 | $45 | $377 |
| Technetium Tc-99m tetrofosmin diagnostic injection A diagnostic injection of Technetium Tc-99m tetrofosmin used for imaging studies. |
38 | $100 | $339 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
37 | $319 | $1,145 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
36 | $97 | $197 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while an electrocardiogram is monitored under physician supervision. |
33 | $15 | $105 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram, with physician review of the results. |
33 | $10 | $174 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
30 | $107 | $218 |
| Continuous EKG monitoring review, 48-7 days Review and interpretation of continuous external EKG recordings lasting more than 48 hours up to 7 days. |
29 | $17 | $61 |
| Transesophageal echocardiogram An ultrasound of the heart performed using a probe inserted into the esophagus to obtain detailed images of heart structures and function. |
29 | $81 | $305 |
| Echocardiogram, transthoracic An ultrasound test that uses sound waves to create images of the heart's blood flow, valves, and chambers. |
29 | $14 | $174 |
| Echocardiogram with color Doppler An ultrasound of the heart that uses color imaging to visualize blood flow, measure flow rate, and assess valve function. |
29 | $2 | $146 |
| Heart muscle strain imaging | 26 | $27 | $97 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
25 | $10 | $80 |
| External EKG monitoring, 8-15 days Continuous external electrocardiogram recording and review over a period of 8 to 15 days to monitor heart rhythm. |
21 | $19 | $67 |
| Continuous external EKG monitoring, 48 hours to 7 days This procedure involves recording the heart's electrical activity continuously using an external device for a period exceeding 48 hours but not more than 7 days. |
17 | $7 | $36 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
15 | $64 | $159 |
| Follow-up heart ultrasound An ultrasound of the heart performed to monitor or reassess a previously identified condition or treatment progress. |
12 | $19 | $95 |
| 2-day continuous ECG with professional review A two-day continuous electrocardiogram recording that includes a review by a healthcare professional. |
11 | $14 | $203 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
12.5% high complexity
21.5% medium
65.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$4,768
Total received (2018-2024)
Avg $681/year across 7 years
Top 35% in PA for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
26
Companies
151
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,461 (93.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$307 (6.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,124
2023
$1,015
2022
$504
2021
$265
2020
$47
2019
$1,554
2018
$260
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$227
AstraZeneca Pharmaceuticals LP
$136
PFIZER INC.
$134
Edwards Lifesciences Corporation
$111
Boehringer Ingelheim Pharmaceuticals, Inc.
$76
E.R. Squibb & Sons, L.L.C.
$72
Alnylam Pharmaceuticals Inc.
$71
Kiniksa Pharmaceuticals International, plc
$62
Janssen Pharmaceuticals, Inc
$50
Amgen Inc.
$41
Medtronic, Inc.
$33
Inspire Medical Systems, Inc.
$28
Novo Nordisk Inc
$26
Actelion Pharmaceuticals US, Inc.
$21
SCPHARMACEUTICALS INC.
$20
Philips North America LLC
$17
Top 3 companies account for 44.2% of 2024 payments
All-time payments by company (2018-2024) ›
Abbott Laboratories
$1,653
AstraZeneca Pharmaceuticals LP
$363
Boehringer Ingelheim Pharmaceuticals, Inc.
$312
Novartis Pharmaceuticals Corporation
$290
E.R. Squibb & Sons, L.L.C.
$276
Janssen Pharmaceuticals, Inc
$247
ABIOMED
$240
HeartFlow, Inc.
$195
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$158
Kestra Medical Technology Services, Inc.
$154
PFIZER INC.
$152
Boston Scientific Corporation
$115
Edwards Lifesciences Corporation
$111
Amgen Inc.
$100
Alnylam Pharmaceuticals Inc.
$71
Kiniksa Pharmaceuticals International, plc
$62
Actelion Pharmaceuticals US, Inc.
$42
SCPHARMACEUTICALS INC.
$38
Medtronic, Inc.
$33
SANOFI-AVENTIS U.S. LLC
$30
CVRx, Inc.
$28
Inspire Medical Systems, Inc.
$28
Novo Nordisk Inc
$26
Philips North America LLC
$17
Merck Sharp & Dohme LLC
$16
Bayer Healthcare Pharmaceuticals Inc.
$13
Top 3 companies account for 48.8% of all-time payments
Associated products mentioned in payments ›
(P77) Azurion 7 M20 · ANDEXXA · ARCTIC FRONT ADVANCE · Arcalyst · Assure WCD · Barostim Neo System · CAMZYOS · ELIQUIS · ENTRESTO · EP-WorkMate Claris System · Ensite Cardiac Mapping System · FARXIGA · FFRct · FUROSCIX · INSPIRE · Impella · JARDIANCE · Kerendia · LEQVIO · LifeVest · MULTAQ · ONPATTRO · OPSUMIT · Ozempic · PULSESELECT · Repatha · VERQUVO · VYNDAMAX · VYNDAQEL · WATCHMAN Access System · WATCHMAN FLX · XARELTO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (94%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Cardiologists within 10 mi
181
Per 100K population
14.6
County median income
$76,393
Nearest hospital
HERITAGE VALLEY SEWICKLEY
3.6 mi
3.6 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Guhl is a cardiac imaging specialist, with moderate Medicare volume, with low-engagement industry engagement.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Guhl experienced with ekg interpretation and report?
Based on Medicare claims data, Dr. Guhl performed 805 ekg interpretation and report services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Guhl receive payments from pharmaceutical companies?
Yes. Dr. Guhl received a total of $4,768 from 26 companies across 151 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Guhl's costs compare to other cardiologists in Leetsdale?
Dr. Guhl's average Medicare payment per service is $48. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Guhl) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Leetsdale
Browse cardiologists in Leetsdale ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in PA
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in PA
Which PA cardiologists receive the most from drug and device companies.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology